Drug Shortage Report for BACTERIOSTATIC WATER FOR INJECTION USP
Report ID | 144270 |
Drug Identification Number | 00038202 |
Brand name | BACTERIOSTATIC WATER FOR INJECTION USP |
Common or Proper name | Bacteriostatic Water For Injection USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | WATER |
Strength(s) | 30ML |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 25 x 30mL vial |
ATC code | V07AB |
ATC description | ALL OTHER NON-THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-08-20 |
Estimated end date | |
Actual end date | 2023-06-05 |
Shortage status | Resolved |
Updated date | 2023-06-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.